ContractPreferred Provider Agreement • May 2nd, 2012 • Bioanalytical Systems Inc • Services-commercial physical & biological research • New York
Portions of this Exhibit 10.30 have been omitted based upon a request for confidential treatment. This Exhibit 10.30, including the non-public information, has been filed separately with the Securities and Exchange Commission. “[*]” designates portions of this document that have been redacted pursuant to the request for confidential treatment filed with the Securities and Exchange Commission.
